Overwatch Research builds Overwatch, a workflow platform designed to run preclinical studies end-to-end, from data collection and task tracking to visualization and lab-specific organizational tools. The product centralizes experimental data, offers instant study visualization, and includes lab-focused features such as spreadsheets for tracking lab animal status. A study creation engine guides study design, suggests appropriate statistical tests, and enforces data formats to reduce bias and faulty analysis. The company emphasizes user experience with a desktop-like interface, a one-hour demo, and roughly five-minute user onboarding. Founded in 2017, Overwatch has closed 20 deals in the U.S., 15 in Europe, a five-year license with a top-10 pharma, and partners with the Institute for Cancer Research, London. The startup plans to expand its U.S. presence, move to Boston, build out sales and marketing, and scale deployments to more labs and drugmakers.

Total raised

$4M

Funding rounds

1

Latest round

Seed

Latest activity

Oct 2021